Adaptive Dual-Target CAR-T Cells

· Beijing Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adaptive Dual-Target CAR-T Cells, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies [Phase 1, Phase 2]